IPO Ideas

Go to page

Browse IPO Ideas — market data, blogs, legal pages, and more.

Invicta Diagnostic Limited IPO logo

Invicta Diagnostic Limited IPO

BBSMENSEListed
Listed at
100
+17.65%

Invicta Diagnostic Limited IPO is a SME book building IPO. Issue size is 28.12 Cr. Price band is ₹80 to ₹85 per share. Minimum investment is ₹2.72 L. Lot size is 1600 shares. Open from 1 Dec 2025 to 3 Dec 2025. Allotment on 4 Dec 2025. Listing on 8 Dec 2025 at NSE. Managed by Socradamus Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Invicta Diagnostic Limited IPO overview

Invicta Diagnostic Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹80 to ₹85
Lot size
1600 shares / lot
Min investment
₹2,72,000
Issue open – close
1 Dec 2025 → 3 Dec 2025

Invicta Diagnostic Limited IPO important dates

Issue Opens
1 Dec 2025
Issue Closes
3 Dec 2025
Allotment
4 Dec 2025
Listing
8 Dec 2025

Invicta Diagnostic Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)23,2002,72,000
S-HNI (Min)34,8004,08,000
S-HNI (UPI)34,8004,08,000
S-HNI (Max)711,2009,52,000
B-HNI (Min)812,80010,88,000

About Invicta Diagnostic Limited IPO

From the company / RHP narrative.

Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.

Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:


A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)
Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.


The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.

Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:


Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.


As of October 31, 2025, the company employed 157 permanent employees.

Competitive Strength:


Expanding presence in the Mumbai Metropolitan Region (“MMR”), specifically in the radiology sector;
A diagnostics provider that offers a one-stop solution at an affordable price.
Technical capability and technology with IT infrastructure;
Dedicated management team with significant industry experience; and
Implementation of the Hub and Spoke Model.

Objective of the issue

How the issuer plans to use IPO proceeds.

Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra; and

General Corporate purposes
Invicta Diagnostic Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Ratings & reviews

Community ratings and reviews — not financial advice.

No ratings yet — be the first to share your experience.

Loading ratings…

Follow the latest IPO & unlisted research on iOS and Android.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
Bigshare Services Pvt Ltd
Phone
2262638200
Address
1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis,Makwana Road, Marol, Andheri(E), Mumbai - 400 059

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
10
Lead Managers
Socradamus Capital Pvt.Ltd.
Min Quantity
3,200
Company Promoters
The Promoters of the Company are Dr. Ketan Jayantilal Jain,Dr. Sanket Vinod Jain,Rohit Prakash Srivastava,Badal Kailash Naredi,Jayesh Prakash Jain.
Phone
022 - 4971 0036
Address
Invicta Diagnostic Ltd. 1 GF, Plot 217, Ambavat Bhavan N.M Joshi Marg Delisle Road Mumbai, Maharashtra, 400013

Related articles

Research posts and updates that reference this company or theme.

Follow the latest IPO & unlisted research on iOS and Android.